• Castelnuovo B, Mannabe YC, Kirraga A, Kamya M, Easterbrook P & Kambugu A (2009) Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort. Clinical Infectious Diseases 49, 965972.
  • Corbett EL, Churchyard GJ, Charalambos S et al. (2002) Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clinical Infectious Diseases 34, 12511258.
  • French N, Gray K, Watera C et al. (2002) Cryptococcal infection in a cohort of HIV-1 infected Ugandan adults. AIDS 16, 10311038.
  • Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R & Harrison TS (2009) Screening for Cryptococcal Antigenaemia in patients accessing an antiretroviral treatment program in South Africa. Clinical Infectious Diseases 48, 856862.
  • Kisenge PR, Hawkins AT, Maro VP et al. (2007) Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania. BMC Infectious Diseases 7, 39.
  • Lara-Peredo O, Cuevas LE, French N, Bailey JW & Smith DH (2000) Cryptococcal infection in an HIV positive Ugandan population. Journal of Infection 41, 195.
  • Meya DB, Manabe YC, Castelnuovo B et al. (2010) Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings. Clinical Infectious Diseases 51, 448455.
  • Okongo M, Morgan D, Mayanja B, Ross A & Whitworth J (1998) Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda. International Journal of Epidemiology 27, 698702.
  • Park BJ, Wannemuehler KA, Marston BJ et al. (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23, 525530.
  • Pongsai P, Atamasirikul K & Sungkanuparph S (2010) The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts. Journal of Infection 60, 474477.
  • Tanner DC, Weinstein MP, Fredorciw B, Joho KL, Thorpe JJ & Reller LB (1994) Comparion of commercial kits for detection of cryptococcal antigen. Journal of Clinical Microbiology 32, 16801684.
  • Tassie JM, Pepper L, Fogg C et al. (2003) Systematic screening of cryptococcal antigenemia in HIV-positive adults in Uganda. Journal of Acquired Immune Deficiency Syndromes 33, 411412.
  • Temstet A, Roux P, Poirot JL, Ronin O & Dromer F (1992) Evaluation of a monoclonal antibody-based latex aggluntination test for the diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies. Journal of Clinical Microbiology 30, 25442550.